Myocarditis Risk Two-Threefold Higher with Moderna Vaccine than Pfizer: JACC Study Kajal Rajput9 Nov 2022 2:30 PM GMTWASHINGTON: Choice of COVID-19 vaccine is indeed dependant on possiblities of side efffects associated with them A study published recently in the...
Interval between Moderna COVID vaccine 2nd shot, booster still 6 months: USFDA Medical Dialogues Bureau4 Jan 2022 4:00 AM GMTWashington: The interval between receiving a second dose of Moderna's COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food...
Moderna and Pfizer vaccines safe with respect to Myocarditis risk, reassures BMJ study Dr. Kamal Kant Kohli17 Dec 2021 12:45 AM GMTA study published by The BMJ provides more reassuring data on the risk ofmyocarditis or myopericarditis after mRNA vaccination against the covid-19...
Moderna vaccine effective against COVID-19 in adolescents: NEJM study dr anusha21 Aug 2021 3:30 AM GMTAlthough Covid-19 illness is generally milder in children than adults, children can have severe disease leading to hospitalization and there is...
Hearing Loss reported after COVID Vaccination, though infrequently MD Bureau24 May 2021 1:53 PM GMTVaccine Adverse Events Reporting System (VAERS) is a national repository of incident reports associated with adverse reactions that occur after any...
Delayed skin reactions to Moderna COVID-19 vaccine reported in NEJM Dr. Kamal Kant Kohli4 March 2021 4:15 AM GMTBoston - Researchers at Massachusetts General Hospital (MGH) have called for greater awareness and communication around a delayed injection-site...
FDA grants EUA to Moderna vaccine for prevention of COVID-19 Dr. Kamal Kant Kohli19 Dec 2020 2:17 AM GMTThe U.S. Food and Drug Administration has issued an emergency use authorization (EUA) to Moderna COVID-19 Vaccine for the prevention of COVID-19...
